INVESTOR.SEATTLEGENETICS.COM HOST
We revealed that the main page on investor.seattlegenetics.com took five hundred and eighty-one milliseconds to come up. I could not observe a SSL certificate, so in conclusion I consider this site not secure.
Internet Protocol
23.0.160.10
PAGE TITLE
Seattle Genetics, Inc. Investors News Investors NewsDESCRIPTION
Transforming cancer treatment and advancing new therapies through empowered science. Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. We are the industry leader in antibody-drug conjugates ADCs, a technology designed to. 160;2455.57. 5,822,044,765. 081715400 pm ET. Minimum 20 minute delay. Seattle Genetics Reports Second Quarter 2015 Financial Results. 073015430 pmET. Medical I.CONTENT
This domain had the following on the web page, "Transforming cancer treatment and advancing new therapies through empowered science." We observed that the web site said " Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer." It also stated " We are the industry leader in antibody-drug conjugates ADCs, a technology designed to. Seattle Genetics Reports Second Quarter 2015 Financial Results."